Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-376-9 | CAS number: 120-20-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Homoveratrylamine (120-20-7) was tested for its mutagenic potential in 10 tester strain of Salmonella Typhimurium and E.coli by Bacterial Mutagen Screen on Gradient Plates with Metabolic Activation. The test result was considered to be negative both in the presence and absence of metabolic activation.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Justification for type of information:
- Data is from publication.
- Qualifier:
- according to guideline
- Guideline:
- other: As mention below
- Principles of method if other than guideline:
- To evaluate the mutagenic potential for Homoveratrylamine in 10 tester strain of Salmonella Typhimurium and E.coli by Bacterial Mutagen Screen on Gradient Plates with Metabolic Activation.
- GLP compliance:
- not specified
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- - Name: 2-(3,4-dimethoxyphenyl)ethan-1-amine
- InChI:1S/C10H15NO2/c1-12-9-4-3-8(5-6-11)7-10(9)13-2/h3-4,7H,5-6,11H2,1-2H3
- Smiles:COc1ccc(CCN)cc1OC
- Name of test material: Homoveratrylamine
- Molecular formula :C10H15NO2
- Molecular weight :181.2335 g/mol
- Substance type:organic - Target gene:
- Histidine for Salmonella Typhimurium and Tryptophan for E.coli
- Species / strain / cell type:
- bacteria, other: Salmonella Typhimurium strain D3052, TA1538, TA98, C3076,TA1537, G46, TA1535, and TA100. E.coli WP2, and WP2 uVrA
- Details on mammalian cell type (if applicable):
- Not applicable
- Additional strain / cell type characteristics:
- other: R-factor plasmids
- Cytokinesis block (if used):
- Not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- Adult male Fischer rats live induced with Aroclor 1254 were used to prepare S9 metabolic activation.
- Test concentrations with justification for top dose:
- 1-1000-µg/ml
- Vehicle / solvent:
- DMSO
- Untreated negative controls:
- yes
- Remarks:
- Plates containing no compound are also prepared to serve as negative controls.
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- other: -S9;streptozotocin +S9;2- acetylaminofluorene
- Details on test system and experimental conditions:
- Details on test system and conditions
METHOD OF APPLICATION: in agar ( plate incorporation Method)
DURATION
- Exposure duration: 48 hour
NUMBER OF CELLS EVALUATED:
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth
NUMBER OF REPLICATIONS:2 plates /concentration - Rationale for test conditions:
- Preliminary work on sup plemental tests using additional tester strains has been done. One important objective was to find a Salmonella tester strain more sensitive than either strains.
- Evaluation criteria:
- Mutagenic concentration range and minimal inhibitory concentration was observed per plates.
- Statistics:
- Yes
- Species / strain:
- bacteria, other: Salmonella Typhimurium strain D3052, TA1538, TA98, C3076,TA1537, G46, TA1535, and TA100. E.coli WP2, and WP2 uVrA
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: No mutagenic effect were observed
- Conclusions:
- Homoveratrylamine (120-20-7) was tested for its mutagenic potential in 10 tester strain of Salmonella Typhimurium and E.coli by Bacterial Mutagen Screen on Gradient Plates with Metabolic Activation. The test result was considered to be negative both in the presence and absence of metabolic activation.
- Executive summary:
Genetic toxicity in vitro study of Homoveratrylamine was assessed for its possible mutagenic potential . For this purpose was Bacterial Mutagen Screen on Gradient Plates method was performed. The advantage of the gradient method is its high capacity. For example, one compound can be evaluated in 10 tester strains over a 10,000-fold concentration range both with and without metabolic activation using only 8 agar plates. The test substance was exposed to S. typhimurium LT-2: G46 (histidine, missense), TA1535 (G46 with gal-bio-uVrB deletion and LPS deletion), TA100 (G46 with gal-bio-uvrB deletion and LPS deletion with the addition of R-factor pKM1O1), C3076 [histidine, (+) frame-shift],TA1537(C3076with gal-bio-uvrB deletion and LPS deletion), D3052 [histidine , (-F) frame-shift], TA1538 (D3052 with gal-bio-uVrB deletion and LPS deletion), and TA98 (D3052 with gal-bio-uvrB deletion and LPS deletion with the addition of A-factor pKM1O1).E.coli : WP2 (E.coli tryptophan) and WP2 uvrA (E. coli tryptophan with uvrA deletion).4 additional strains are used for supple mental testing. These strains are TA92 (G46 with the addition of A-factor pKM1O1), TA94 (D3052 with the addition of R-factor pKM1O1), CM881 (WP2 with the addition of R factor pKM1O1), and CM891 (WP2 with uVrA deletion and with the addition of A-factor pKM1O1) at the concentration of 1-1000-µg/ml. The test substance was exposed in the presence and absence of metabolic activation. No mutagenic effects were observed. Therefore Homoveratrylamine was considered to be non mutagenic in Salmonella Typhimurium strainD3052, TA1538, TA98, C3076,TA1537, G46, TA1535,TA100 and E.coli WP2, WP2 uVrA in thepresence and absence of metabolic activation. Hence the substance cannot be classified as gene mutant in vitro.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Genetic toxicity In-vitro
Various experimental studies were reviewed to determine the mutagenic nature of target substance Homoveratrylamine (120-20-7). The studies are as mentioned below:
Gene mutation toxicity study was performed by Robert E. McMahon .et al (CANCER RESEARCH, 1979) to determine the mutagenic nature of target substance Homoveratrylamine (120-20-7) using Bacterial strain. Genetic toxicity in vitro study of Homoveratrylamine was assessed for its possible mutagenic potential. For this purpose was Bacterial Mutagen Screen on Gradient Plates method was performed. The advantage of the gradient method is its high capacity. For example, one compound can be evaluated in 10 tester strains over a 10,000-fold concentration range both with and without metabolic activation using only 8 agar plates. The test substance was exposed to S. typhimurium LT-2: G46 (histidine, missense), TA1535 (G46 with gal-bio-uVrB deletion and LPS deletion), TA100 (G46 with gal-bio-uvrB deletion and LPS deletion with the addition of R-factor pKM1O1), C3076 [histidine, (+) frame-shift],TA1537(C3076with gal-bio-uvrB deletion and LPS deletion), D3052 [histidine , (-F) frame-shift], TA1538 (D3052 with gal-bio-uVrB deletion and LPS deletion), and TA98 (D3052 with gal-bio-uvrB deletion and LPS deletion with the addition of A-factor pKM1O1).E.coli : WP2 (E.coli tryptophan) and WP2 uvrA (E. coli tryptophan with uvrA deletion).4 additional strains are used for supple mental testing. These strains are TA92 (G46 with the addition of A-factor pKM1O1), TA94 (D3052 with the addition of R-factor pKM1O1), CM881 (WP2 with the addition of R factor pKM1O1), and CM891 (WP2 with uVrA deletion and with the addition of A-factor pKM1O1) at the concentration of 1-1000-µg/ml. The test substance was exposed in the presence and absence of metabolic activation. No mutagenic effects were observed. Therefore Homoveratrylamine was considered to be non mutagenic in Salmonella Typhimurium strainD3052, TA1538, TA98, C3076,TA1537, G46, TA1535,TA100 and E.coli WP2, WP2 uVrA in the presence and absence of metabolic activation. Hence the substance cannot be classified as gene mutant in vitro.
In a study functionally similar read across chemical, Gene mutation toxicity study was performed by James C. Ball et al. (Mutation Research, 1984) to determine the mutagenic nature of. The read across substances share high similarity in functional group. Therefore, it is acceptable to derive information on mutation from the analogue substance. Ames Salmonella plate-incorporation assay was performed to determine the mutagenic nature of p-methylbenzyl alcohol. The study was performed on Salmonella typhimurium strain TA100 and TA98 as per the plate incorporation assay. A compound was considered to be mutagenic if the number of revertants/plate exceeded the 99.9% confidence limit and a concentration-dependent increase in the Mutagenicity was observed. The 99.9% confidence limit was 99 revertants above spontaneous revertant levels for TA100 (spontaneous revertants = 196±29 revertants/plate) and 40 revertants above spontaneous revertants for TA98 (spontaneous revertants = 40±12 revertants/plate). p-methylbenzyl alcohol failed to induce mutation in Salmonella typhimurium strain TA100 and TA98 and hence does not classify as a gene mutant in vitro.
In a study functionally similar read across chemical, Gene mutation toxicity study was performed by D. Wildet al. (Food and chemical toxicology,1983) to determine the mutagenic nature 4-(4-Methoxyphenyl)butan-2-one (104-20-1). The read across substances share high similarity in functional group .Therefore, it is acceptable to derive information on mutation from the analogue substance. Gene mutation toxicity study was performed to determine the mutagenic nature of 4-(4-Methoxyphenyl)butan-2-one (Anisyl acetone). The study was perfomed as per the standard plate procedure using Salmonella typhimurium strains TA1535, TA100, TA1537, TA1538, TA98 in the presence and absence of S9 metabolic activation system. The test chemical was dissolved in DMSO and used upto doses of 3.6 mg/plate. The plates were incubated for 48 hrs. 4-(4-Methoxyphenyl)butan-2-one (Anisyl acetone) did not induce gene mutation in Salmonella typhimurium strains TA1535, TA100, TA1537, TA1538, TA98, test substance in the presence and absence of S9 metabolic activation system and hence it is not likely to classify as a gene mutant.
Based on the data available for the target chemical and its read across substance and applying weight of evidence Homoveratrylamine (120-20-7) does not exhibit gene mutation in vitro. Hence the test chemical is not likely to classify as a gene mutant in vitro.
Justification for classification or non-classification
Thus based on the above annotation and CLP criteria for the target chemical Homoveratrylamine (120-20-7) does not exhibit gene mutation in vitro. Hence the test chemical is not likely to classify as a gene mutant in vitro.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.